Kidney function, albuminuria and cardiovascular risk factors in post-operative living kidney donors: A single-center, cross-sectional study.

Clinical and Experimental Nephrology

Volumn 15, Issue 4, 2011, Pages 514-521

  Yazawa, Masahiko ^a   Kido, Ryo ^b   Shibagaki, Yugo ^a   Yasuda, Takashi ^a   Nakazawa, Ryuto ^a   Sasaki, Hideo ^a   Sato, Yuichi ^a   Chikaraishi, Tatsuya ^a   Kimura, Kenjiro ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Albuminuria; Cardiovascular riskfactor; Kidney function; Living kidney donor

Indexed keywords

ADULT; ALBUMINURIA; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; DYSLIPIDEMIA; FEMALE; GLUCOSE INTOLERANCE; HUMAN; HYPERTENSION; HYPERURICEMIA; INULIN CLEARANCE; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVING KIDNEY DONOR; MALE; METABOLIC SYNDROME X; OBESITY; POSTOPERATIVE PERIOD; PREVALENCE;

EID: 85027948973     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-011-0441-1     Document Type: Article

References (42)

1. Horvat LD, Shariff SZ, Garg AX. Global trends in the rates of living kidney donation. Kidney Int. 2009;75:1088-98
2. The Japanese Society for Clinical Renal Transplantation. Annual Progress Report from Japanese Renal Transplant Registry: Number of Renal Transplantation in 2008, part 2. Isyoku. 2009;44:548-58 (in Japanese)
3. Ibrahim HN, Foley R, Tan L, Rogers T, Bailey RF, Guo H, et al. Long-term consequences of kidney donation. N Engl J Med. 2009;360:459-69
4. Segev DL, Muzaale AD, Caffo BS, Mehta SH, Singer AL, Taranto SE, et al. Perioperative mortality and long-term survival following live kidney donation. JAMA. 2010;303:959-66
5. Fehrman-Ekholm I, Elinder CG, Stenbeck M, Tyden G, Groth CG. Kidney donors live longer. Transplantation. 1997;64:976-8 (Pubitemid 27446761)
6. Garg AX, Prasad GV, Thiessen-Philbrook HR, Ping L, Melo M, Gibney EM, Donor Nephrectomy Outcomes Research (DONOR) Network, et al. Cardiovascular disease and hypertension risk in living kidney donors: An analysis of health administrative data in Ontario, Canada. Transplantation. 2008;86:399-406
7. Okamoto M, Akioka K, Nobori S, Ushigome H, Kozaki K, Kaihara S, et al. Short- and long-term donor outcomes after kidney donation: Analysis of 601 cases over a 35-year period at Japanese single center. Transplantation. 2009;87:419-23
8. Kido R, Shibagaki Y, Iwadoh K, Nakajima I, Fuchinoue S, Fujita T, et al. How do living kidney donors develop end-stage renal disease? Am J Transplant. 2009;9:2514-9
9. Boudville N, Prasad GV, Knoll G, Muirhead N, Thiessen-Philbrook H, Yang RC, Donor Nephrectomy Outcomes Research (DONOR) Network, et al. Meta-analysis: Risk for hypertension in living kidney donors. Ann Intern Med. 2006;145:185-96 (Pubitemid 46780564)
10. Garg AX, Muirhead N, Knoll G, Yang RC, Prasad GV, Thiessen- Philbrook H, Donor Nephrectomy Outcomes Research (DONOR) Network, et al. Proteinuria and reduced kidney function in living kidney donors: A systematic review, meta-analysis, and metaregression. Kidney Int. 2006;70:1801-10 (Pubitemid 44684812)
11. Rizvi SA, Naqvi SA, Jawad F, Ahmed E, Asghar A, Zafar M, et al. Living kidney donor follow-up in a dedicated clinic. Transplantation. 2005;79:1247-51 (Pubitemid 40664033)
12. Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, et al. Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract. 2002;55:65-85 (Pubitemid 34036538)
13. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1-266
14. Horio M, Yasuda Y, Takahara S, Imai E, Watanabe T, Matsuo S. Comparison of a simple and a standard method for inulin renal clearance. Clin Exp Nephrol. 2010;14(5):427-30
15. Horio M, Imai E, Yasuda Y, Hishida A, Matsuo S, Japanese Equation for Estimating GFR. Simple sampling strategy for measuring inulin renal clearance. Clin Exp Nephrol. 2009; 13:50-4
16. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982-92
17. Matsuzawa Y. Metabolic syndrome-definition and diagnostic criteria in Japan. J Jpn Soc Med. 2005;94:188-203
18. Hakoda M. Epidemiology of hyperuricemia and gout in Japan. Nippon Rinsho. 2008;66:647-52 (in Japanese)
19. Kido R, Shibagaki Y, Iwadoh K, Nakajima I, Fuchinoue S, Fujita T, et al. Very low but stable glomerular filtration rate after living kidney donation: Is the concept of "chronic kidney disease" applicable to kidney donors? Clin Exp Nephrol. 2010;14:356-62
20. Kakuta Y, Okumi M, Ichimaru N, Abe T, Nonomura N, Okuyama A, et al. Utility of the Japanese GFR estimation equation for evaluating potential donor kidney function. Clin Exp Nephrol. 2010;14:63-7
21. Tan JC, Ho B, Busque S, Blouch K, Derby G, Efron B, et al. Imprecision of creatinine-based GFR estimates in uninephric kidney donors. Clin J Am Soc Nephrol. 2010;5:497-502
22. Imai E. Equation for estimating GFR from creatinine in Japan. Nippon Rinsho. 2008;66:1725-9 (in Japanese)
23. Iseki K. Chronic kidney disease in Japan. Intern Med. 2008;47:681-9 (Pubitemid 351936214)
24. Imai E, Horio M, Yamagata K, Iseki K, Hara S, Ura N, et al. Slower decline of glomerular filtration rate in the Japanese general population: A longitudinal 10-year follow-up study. Hypertens Res. 2008;31:433-41 (Pubitemid 351597496)
25. Iseki K, Kinjo K, Iseki C, Takishita S. Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan. Am J Kidney Dis. 2004;44:806-14 (Pubitemid 39445912)
26. Nakayama M, Metoki H, Terawaki H, Ohkubo T, Kikuya M, Sato T, et al. Kidney dysfunction as a risk factor for first symptomatic stroke events in a general Japanese population-the Ohasama study. Nephrol Dial Transplant. 2007;22:1910-5 (Pubitemid 47244759)
27. Konta T, Hao Z, Abiko H, Ishikawa M, Takahashi T, Ikeda A, et al. Prevalence and risk factor analysis of microalbuminuria in Japanese general population: The Takahata study. Kidney Int. 2006;70:751-6 (Pubitemid 44215351)
28. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, Japanese Society of Hypertension Committee, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res. 2009; 32:3-107
29. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: The Ohasama study. J Hypertens. 2002;20:2183-9 (Pubitemid 35388236)
30. Hoshide S, Kario K, Hoshide Y, Umeda Y, Hashimoto T, Kunii O, et al. Associations between nondipping of nocturnal blood pressure decrease and cardiovascular target organ damage in strictly selected community-dwelling normotensives. Am J Hypertens. 2003;16:434-8 (Pubitemid 36667796)
31. Eberhard OK, Kliem V, Offner G, Oldhafer K, Fangmann J, Pichlmay R, et al. Assessment of long-term risks for living related kidney donors by 24-h blood pressure monitoring and testing for microalbuminuria. Clin Transplant. 1997;11:415-9 (Pubitemid 27460437)
32. Fukuda M, Goto N, Kimura G. Hypothesis on renal mechanism of non-dipper pattern of circadian blood pressure rhythm. Med Hypotheses. 2006;67:802-6 (Pubitemid 44096890)
33. Hakoda M. Epidemiology of hyperuricemia and gout in Japan. Nippon Rinsho. 2008;66:647-52 (in Japanese)
34. Madero M, Sarnak MJ, Wang X, Greene T, Beck GJ, Kusek JW, et al. Uric acid and long-term outcomes in CKD. Am J Kidney Dis. 2009;53:796-803
35. Okamoto M, Suzuki T, Fujiki M, Nobori S, Ushigome H, Sakamoto S, et al. The consequences for live kidney donors with preexisting glucose intolerance without diabetic complication: Analysis at a single Japanese center. Transplantation. 2010;89: 1391-5
36. Muntner P, He J, Astor BC, Folsom AR, Coresh J. Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: Results from the atherosclerosis risk in communities study. J Am Soc Nephrol. 2005;16:529-38 (Pubitemid 41725151)
37. Schaeffner ES, Kurth T, Curhan GC, Glynn RJ, Rexrode KM, Baigent C, et al. Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol. 2003;14:2084-91 (Pubitemid 36909916)
38. Appel GB, Radhakrishnan J, Avram MM, DeFronzo RA, Escobar- Jimenez F, Campos MM, BMRENAAL Study, et al. Analysis of metabolic parameters as predictors of risk in the RENAAL study. Diabetes Care. 2003;26:1402-7 (Pubitemid 36929170)
39. Delmonico F, Council of the Transplantation Society. A report of the Amsterdam forum on the care of the live kidney donor: Data and medical guidelines. Transplantation. 2005;79:S53-66 (Pubitemid 40446548)
40. Issa N, Stephany B, Fatica R, Nurko S, Krishnamurthi V, Goldfarb DA, et al. Donor factors influencing graft outcomes in live donor kidney transplantation. Transplantation. 2007;83:593-9 (Pubitemid 46440249)
41. Health and Welfare Statistics Association. J Health Welf Stat. 2009;56:84
42. Praga M, Hernandez E, Herrero JC, Morales E, Revilla Y, Diaz- Gonzalez R, et al. Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int. 2000;58:2111-8.